Latest Pyrrolidines Stories

For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs

2013-05-20 12:24:37

Phase III Clinical Data Indicate That Indacaterol/Glycopyrronium Has Advantages Over Current Therapies for Efficacy, According to a New Report from Decision Resources BURLINGTON, Mass., May 20, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European pulmonologists agree that therapies offering a greater effect on quality of life is among the areas of highest unmet...

Cardiome Reports First Quarter Results

2013-05-13 08:29:35

Cardiome to conduct conference call and webcast today, May 13, at 4:15 p.m. Eastern (1:15 p.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER, May 13, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the first quarter ended March 31, 2013. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP). All...

Cardiome To Present At Bloom Burton & Co. Healthcare Investor Conference

2013-05-10 08:24:26

NASDAQ: CRME TSX: COM VANCOUVER, May 10, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced President & CEO, Dr. William Hunter, is presenting an update of the Company's progress at the Bloom Burton & Co. Healthcare Investor Conference at the Toronto Board of Trade in Toronto on May 22, 2013. Dr. Hunter's presentation will include an update of the Company's business including the recent launch of BRINAVESS(TM) in Europe by the...

ACE Inhibitors Could Reduce Radiotherapy Damage To Heart and Lungs

2013-04-21 08:11:24

redOrbit Staff & Wire Reports - Your Universe Online Damage to the heart and lungs caused by treating tumors in a person’s chest area can be limited through the use of drug typically used to treat cardiovascular disease, a team of Dutch researchers claim in a new study. Dr. Sonja Van der Veen of the University Medical Centre, Groningen (UMCG), and colleagues intended to find out whether or not angiotensin-converting enzyme (ACE) inhibitors could help prevent a condition known as...

Egg Whites Found To Lower Blood Pressure

Eggs Found To Lower Blood Pressure, Further Rebounding Their Reputation

2013-04-10 12:24:18

Brett Smith for redOrbit.com - Your Universe Online Once derided as an unhealthy indulgence, the reputation of the “incredible edible egg” has been on the rebound in recent years with the release of numerous studies showing its health benefits. One of those studies, presented at the 245th National Meeting & Exposition of the American Chemical Society (ACS) in New Orleans, showed that a component of egg whites can actually lower blood pressure. "Our research suggests that...

Genetic Markers For Smoking Predict Risk 032813

Genetic Markers For Smoking May Help Predict Who Gets Hooked

2013-03-28 11:19:07

Brett Smith for redOrbit.com - Your Universe Online According to a new study in JAMA Psychiatry, a team of international scientists has developed a genetic profile that indicates a greater risk for a teenager's progression into becoming a lifelong heavy smoker. People who share the genetic profile showed a greater risk of daily smoking as teenagers and then progressing more rapidly to smoking a pack a day or more as adults, the study said. High-risk individuals who were assessed in...

Cardiome Announces The Addition Of Dr. Steen Juul-Moller As Medical Director, Europe

2013-03-28 08:28:02

NASDAQ: CRME TSX: COM VANCOUVER, March 28, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME) (TSX: COM) today announces the addition of Steen Juul-Möller, M.D., Ph.D./DMSc., FESC to Cardiome's management team as Medical Director, Europe. In his capacity of Medical Director, Dr. Juul-Möller will oversee Cardiome's clinical and medical affairs activities. Dr. Juul-Möller has held his clinical position at the Malmö University Hospital (now Skane University...

Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Cardiome Shareholders Vote in Favor of Share Consolidation

2013-03-19 16:29:24

NASDAQ: CRME TSX: COM VANCOUVER, March 19, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co., two leading independent proxy research and advisory firms, have published reports recommending that Cardiome shareholders vote FOR a share consolidation resolution, authorizing the Board of Directors to effect, in its discretion, a share consolidation of the outstanding...

Cardiome Reports Fourth Quarter and Full Year 2012 Financial Results

2013-03-15 08:26:23

Cardiome to conduct conference call and webcast today, March 15, at 8:15 a.m. Eastern (5:15 a.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER, March 15, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the fourth quarter and year ended December 31, 2012. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States (U.S....

Cardiome to Hold Fourth Quarter and Full Year 2012 Financial Results Conference Call on March 15

2013-03-12 16:23:32

NASDAQ: CRME TSX: COM VANCOUVER, March 12, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report financial results for the fourth quarter and fiscal year ended December 31, 2012 on the morning of Friday, March 15, 2013. Cardiome will hold a conference call and webcast at 8:15 a.m. Eastern (5:15 a.m. Pacific) on that day to discuss the results. To access the conference call, please dial 416-764-8688 or 888-390-0546 and use...